Pharmafile Logo
Pharmafocus logo
Advanced Search

Psoriasis treatment bimekizumab maintains high Levels of skin clearance

August 9, 2021
Sales and Marketing

New two-year data has shown that bimekizumab maintained high Levels of skin clearance in patients with moderate to severe plaque …

News
az

First new adult CDK treatment in 20 years gains UK and EU approval

August 9, 2021
Medical Communications, Research and Development, Sales and Marketing

AstraZeneca has announced the EU approval of Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, alongside a licence extension from …

News

FDA approves Nexviazyme as treatment for late-onset Pompe disease

August 9, 2021
Sales and Marketing

The FDA has approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients one year of age and older with late-onset …

News
az

Sierra Oncology to licence myelofibrosis candidate from AstraZeneca

August 6, 2021
Medical Communications, Research and Development, Sales and Marketing

Under a new agreement announced on Friday, AstraZeneca will licence AZD5153, a potent and selective BRD4 BET inhibitor with a …

News
biktarvy-descovy-bottles

Gilead warns of counterfeit HIV medication being distributed in US

August 6, 2021
Medical Communications

Gilead have released a statement warning of tampered and counterfeit versions of its once-daily single tablet HIV treatment regimen Biktarvy …

News
sanofi_hq__boetie_hall_small_

Libtayo Phase III Trial stopped early due to significant improvement in overall survival

August 6, 2021
Medical Communications

The Phase III trial of Sanofi and Regeneron’s PD-1 inhibitor Libtayo in combination with platinum-doublet chemotherapy was stopped early due …

News

FDA grants Orphan Drug Designation to sotigalimab for soft tissue sarcoma

August 6, 2021
Medical Communications

The FDA has granted Apexigen’s sotigalimab (APX005M) Orphan Drug Designation for the treatment of soft tissue sarcoma.Sotigalimab, Apexigen’s lead therapeutic …

News

Cholesterol pill could cut COVID infections by up to 70%, study finds

August 6, 2021
Medical Communications, Research and Development

A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce COVID infections by …

News

Fresenius launches VR training for home dialysis in Germany

August 5, 2021

Fresenius has launched a virtual reality-based training programme, stay safe My Training VR, for people undergoing at home dialysis.The VR …

News

Study finds pressured oxygen reduces ventilator need in COVID patients

August 5, 2021
Medical Communications

Treating COVID patients with acute respiratory failure with continuous positive airway pressure (CPAP) reduces the need for invasive mechanical ventilation, …

News
nice_new_london_office_internal_2_88

NICE and AHSN to collaborate on best evidence-based healthcare

August 5, 2021

NICE and the Academic Health Science Network (AHSN) are to collaborate on best evidence-based healthcare to improve the lives of …

News
pfizer_building_logo2_1_3

CMA accuses Pfizer and Flynn of overcharging the NHS

August 5, 2021

Having gathered further evidence, the CMA has reached a provisional view that Pfizer and Flynn broke competition law by charging …

News

One in five of all UK COVID hospital admissions are aged 18-34

August 5, 2021

One fifth of all UK COVID hospital admissions are now from people aged 18-34, which is four times higher than …

News

Tokyo COVID: Cases surge as Delta variant takes hold, hospital policy U-turn expected

August 4, 2021
Medical Communications, Research and Development

Japan has warned that COVID-19 cases are surging at an ‘unprecedented pace’, hitting record highs in Tokyo amid the Olympic …

News

Delta surge: China reports highest rate of new COVID cases since Jan

August 4, 2021
Medical Communications, Research and Development

On Wednesday China reported the highest number of new locally transmitted COVID-19 cases since January, with case numbers being driven …

News

Chilean study reveals success of various COVID-19 vaccines

August 4, 2021
Research and Development

Chilean authorities have released real world data on the varied success of the Sinovac, Pfizer, and AstraZeneca COVID-19 vaccines.Among the …

News
lilly_entrance_web_42

Eli Lilly to seek approval for experimental Alzheimer’s drug by end of year

August 4, 2021
Research and Development

Eli Lilly and Co plans to seek US approval for its experimental Alzheimer’s drug by the end of the year, …

News

Over 1 million 16 and 17-year-olds set to be offered vaccine in UK

August 4, 2021
Research and Development

UK experts are near announcing that all 16 and 17-year-olds should be offered a COVID vaccine in the UK, as …

News

Novartis set to launch new Zolgensma trial to expand use

August 3, 2021
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has announced that it will launch a new Phase III study to expand the use of Zolgensma – the …

News

Cannabis-based oral spray could kill brain tumours, study to launch next year

August 3, 2021
Manufacturing and Production, Medical Communications, Research and Development

The NHS alongside cancer charities are set to launch a clinical trial to investigate the effects of a cannabis-based oral …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026